Core Points - Fortive Corporation will be presenting at the Baird 2025 Global Industrial Conference on November 11, 2025, at 4:05 p.m. CT [1] - The presentation will be led by Olumide Soroye, President and Chief Executive Officer of Fortive [1] - The audio of the presentation will be available via a simultaneous webcast and archived on Fortive's official website [1] Company Overview - Fortive innovates essential technologies aimed at enhancing safety and productivity [1] - The company operates through strategic segments, although specific segments are not detailed in the provided content [1]

Core Insights - Fortive Corporation reported third-quarter 2025 adjusted earnings per share (EPS) of 68 cents, exceeding the Zacks Consensus Estimate of 58 cents, marking a year-over-year increase of 15.3% [1][9] - Revenues for the quarter rose 2.3% year over year to $1.03 billion, surpassing the Zacks Consensus Estimate by 2.1%, with core revenues increasing by 1.9% [1][9] Financial Performance - The company executed $1 billion in share repurchases during the quarter, reflecting its disciplined capital allocation strategy [3] - Fortive raised its full-year 2025 EPS guidance to a range of $2.63 to $2.67, up from the previous estimate of $2.50 to $2.60, due to strong third-quarter performance [4][12] - As of September 26, 2025, cash and cash equivalents were $430.8 million, down from $1,827.4 million as of June 27, 2025 [11] Segment Performance - Intelligent Operating Solutions generated revenues of $698.8 million, contributing 68% to total revenues, with a year-over-year increase of 2.6% [6] - Advanced Healthcare Solutions reported revenues of $328.3 million, accounting for 32% of total revenues, up 1.8% year over year [6] - Adjusted operating margins for Intelligent Operating Solutions were 32.8%, expanding 110 basis points year over year, while Advanced Healthcare Solutions saw adjusted operating margins of 26.7%, rising 130 basis points [10] Outlook - The company anticipates overall core growth to moderate in the fourth quarter, with Advanced Healthcare Solutions core growth expected to remain in line with third-quarter levels [13] - Fortive expects a sequential increase in net interest expense in the fourth quarter and maintains a projected adjusted effective tax rate in the mid-teens for 2025 [13]

Core Insights - The manufacturing sector is facing a significant crisis due to unplanned downtime, with 61 percent of manufacturers experiencing such incidents in the past year, leading to weekly losses of up to $852 million [1][10] Summary by Sections Survey Findings - A survey conducted by Censuswide included over 600 senior decision-makers and maintenance professionals from the U.S., UK, and Germany [2][12] - Among the affected manufacturers, 48 percent reported experiencing 6–10 downtime incidents weekly, while 19 percent faced 11–20 incidents [2][13] - The duration of outages is concerning, with 45 percent of respondents indicating that outages last up to 12 hours, and 15 percent reporting incidents lasting up to 72 hours [2][13] Financial Impact - The average cost of downtime is estimated at $1.7 million per hour, with a single incident potentially resulting in losses of up to $42.6 million, equivalent to powering 2,500 manufacturing facilities for a week [3][13] - The financial implications of downtime represent a recurring operational challenge and a significant risk to profitability and resilience at the board level [3][6] Organizational Challenges - Large enterprises, particularly those with over 50,000 employees, report more severe risks, with 40 percent experiencing 11–20 downtime incidents weekly and 50 percent facing outages lasting up to 72 hours [4] - The industry’s response to downtime is fragmented, with manufacturers investing in various digital solutions such as predictive maintenance (12 percent), digital twins (12 percent), and condition monitoring (13 percent) [5] Strategic Recommendations - Fluke Corporation emphasizes the need for manufacturers to shift from reactive to proactive strategies regarding downtime, highlighting that quick fixes do not foster long-term resilience [6] - A clear plan to scale digital investments is essential, as current efforts are too dispersed to create a lasting impact [7]

Core Insights - Fortive Corporation exceeded earnings expectations, reporting adjusted EPS of $0.68 compared to an estimate of $0.57, indicating strong financial performance [1] - The company has raised its full-year guidance, suggesting confidence in future growth and operational stability [1] Financial Performance - Adjusted EPS reported at $0.68, surpassing the $0.57 estimate, reflecting a positive earnings surprise [1] - The increase in earnings may indicate effective cost management and revenue growth strategies [1] Future Outlook - The raised full-year guidance signals optimism about the company's performance in the upcoming quarters [1] - This adjustment in guidance may attract investor interest and positively influence stock performance [1]

Financial Data and Key Metrics Changes - In Q3, total revenue was just over $1 billion, reflecting a year-over-year increase of approximately 2% on both a reported and core basis [12][13] - Adjusted EBITDA grew by 10% year-over-year to $309 million, with an adjusted EBITDA margin expanding approximately 200 basis points to 30% [14][12] - Adjusted EPS increased by 15% year-over-year to $0.68, driven by growth in adjusted EBITDA and favorable interest expense [14][12] - Free cash flow for Q3 was $266 million, with trailing twelve-month free cash flow growing to $922 million [15][20] Business Line Data and Key Metrics Changes - Intelligent Operating Solutions (iOS) segment revenue grew just over 2.5% on a reported basis, with core revenue growth at 2% [15][16] - Advanced Healthcare Solutions (AHS) segment revenue was $328 million, growing approximately 2% year-over-year, with adjusted EBITDA margin expanding from roughly 27% to 28% [18][17] Market Data and Key Metrics Changes - North America showed solid growth, improving sequentially from Q2, driven by strengthening demand trends for professional instrumentation and healthcare equipment [13][12] - Europe experienced a year-over-year decline, worsened by weakening macro conditions [13] - The rest of the world showed mixed results, with significant acceleration in South Asia, particularly India [10][12] Company Strategy and Development Direction - The company is focused on driving profitable organic growth through the Fortive Business System, with a strategy centered on innovation acceleration, commercial acceleration, and recurring customer value [8][9] - Capital allocation priorities include investing in organic growth, pursuing accretive bolt-on M&A, returning capital through share repurchases, and maintaining a modest growing dividend [11][10] - The company is committed to maximizing medium to long-term shareholder returns through disciplined capital allocation [25][24] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the company's growth trajectory, emphasizing the benefits of simplification and a customer-centric approach [23][24] - The outlook for Q4 anticipates a moderation in overall core growth, with AHS core growth expected to be broadly in line with Q3 levels [21][22] - Management remains confident in the resilience of healthcare spending despite potential policy changes, citing strong customer loyalty and ongoing demand trends [104][105] Other Important Information - The company successfully completed the spin-off of its Precision Technologies segment, now operating independently as Rallian [3] - The company has revamped its M&A strategy to focus on smaller, bolt-on acquisitions rather than transformational M&A [41][42] Q&A Session Summary Question: Margin performance and Q4 guidance - Management acknowledged that Q3 margin performance was aided by cost discipline and discrete actions taken to free up resources for growth initiatives, with expectations for some reinvestment in Q4 [31][32] Question: Impact of government shutdown - Management indicated that the federal government shutdown has not significantly impacted their business, as their exposure is primarily to state and local agencies [34][35] Question: Capital allocation and buybacks - The company expressed satisfaction with the $1 billion share repurchase in Q3, reflecting strong free cash flow and attractive valuations, while emphasizing a balanced approach to capital allocation between buybacks and bolt-on M&A [40][41] Question: Demand trends in AHS - Management reported sequential improvement in demand for healthcare capital equipment in North America, driven by increased certainty around legislative conditions [58][59] Question: Software business performance - The software segment continues to perform well, with strong demand for facilities software and ongoing product innovation [66][67] Question: Simplification impact on growth - Management expects increasing impact from simplification efforts as they continue to free up resources for growth initiatives [75][76] Question: Regional demand trends - North America remains the strongest market, while Western Europe has been the softest, with mixed results in other regions [78][79]

Financial Data and Key Metrics Changes - In Q3, total revenue was just over $1 billion, reflecting a year-over-year increase of approximately 2% on both a reported and core basis [12][13] - Adjusted EBITDA was $309 million, up 10% year-over-year, with an adjusted EBITDA margin expanding approximately 200 basis points to 30% [14][15] - Adjusted EPS was $0.68, representing a 15% year-over-year increase, driven by growth in adjusted EBITDA and favorable interest expense [14][15] Business Line Data and Key Metrics Changes - **Intelligent Operating Solutions (iOS)**: Revenue grew just over 2.5% on a reported basis, with core revenue growth at 2%. Growth was driven by demand for facility and asset lifecycle software and professional instrumentation [15][16] - **Advanced Healthcare Solutions (AHS)**: Total revenue was $328 million, growing approximately 2% year-over-year. Demand trends improved sequentially, particularly for healthcare equipment and software [18][19] Market Data and Key Metrics Changes - North America showed solid growth, improving sequentially from Q2, driven by strengthening demand trends for professional instrumentation and healthcare equipment [13][18] - Europe experienced a decline year-over-year, worsened by weakening macro conditions [13] - The rest of the world showed mixed results, with significant acceleration in South Asia, particularly India [10][13] Company Strategy and Development Direction - The company is focused on driving profitable organic growth through its Fortive Business System, emphasizing innovation acceleration, commercial acceleration, and recurring customer value [8][10] - Capital allocation priorities include investing in organic growth, pursuing accretive bolt-on M&A, returning capital through share repurchases, and maintaining a modest growing dividend [11][19] - The company aims to simplify operations and enhance customer-centric approaches, which are expected to yield positive outcomes in the future [23][24] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the company's growth trajectory, citing strong customer relationships and a robust pipeline of growth opportunities [24][25] - The company anticipates a moderation in overall core growth in Q4, with AHS core growth expected to align with Q3 levels [21][22] - Management remains confident in the healthcare market's resilience despite potential policy changes, driven by aging demographics and increasing healthcare needs [105][106] Other Important Information - The company successfully completed the spin-off of its Precision Technologies segment, now operating as Rallian, on June 28, 2025 [3][4] - The company deployed $1 billion for share repurchases in Q3, retiring approximately 21 million shares, reflecting confidence in its value creation plan [7][19] Q&A Session Summary Question: Margin performance and Q4 guidance - Management acknowledged that Q3 margin performance was aided by cost discipline and discrete actions taken to free up resources for growth initiatives, with expectations to maintain cost discipline in Q4 [31][32] Question: Impact of government shutdown - Management indicated that the federal government shutdown has minimal direct exposure for the company, primarily affecting state and local government agencies [34][35] Question: Capital allocation and M&A strategy - Management confirmed that share repurchases will be a significant part of capital allocation, focusing on smaller bolt-on acquisitions rather than transformational M&A [40][42] Question: Fluke performance and demand indicators - Management reported strong order growth and stable sell-through patterns for Fluke, with improvements in channel inventory and ongoing product innovation [43][44] Question: AHS segment demand trends - Management noted sequential improvement in demand for healthcare capital equipment and consumables, driven by more certainty in legislative conditions [56][58] Question: Tax rate outlook - Management projected a mid-teens effective tax rate for the next few years, with potential risks from new proposals [59][60] Question: Software business performance - Management highlighted strong growth in the software segment, particularly in AI-related applications, and noted that IT spending remains robust [66][68] Question: Demand trends by region - Management indicated strong performance in North America, while Western Europe remains soft, with mixed results in other regions [78][79]

Financial Data and Key Metrics Changes - In Q3 2025, total revenue was just over $1 billion, reflecting a year-over-year increase of approximately 2% on both a reported and core basis [11] - Adjusted EBITDA grew by 10% year-over-year to $309 million, with an adjusted EBITDA margin expanding by approximately 200 basis points to 30% [12] - Adjusted EPS was $0.68, up 15% year-over-year, driven by growth in adjusted EBITDA and favorable interest expense on lower debt balances [12][19] Business Line Data and Key Metrics Changes - Intelligent Operating Solutions (iOS) segment revenue grew just over 2.5% on a reported basis, with core revenue growth at 2% [14] - Advanced Healthcare Solutions (AHS) segment revenue was $328 million, growing approximately 2% year-over-year, with adjusted EBITDA margin expanding from roughly 27% to 28% [17] Market Data and Key Metrics Changes - North America showed solid growth, improving sequentially from Q2, driven by strengthening demand trends for professional instrumentation and healthcare equipment [11] - Europe experienced a year-over-year decline, worsened modestly from Q2 due to weakening macro conditions [11] - The rest of the world showed mixed results, with significant acceleration in South Asia, particularly India, which is expected to drive strong momentum in the coming years [9] Company Strategy and Development Direction - The company is focused on driving profitable organic growth through its Fortive Business System, with a strategy centered on innovation acceleration, commercial acceleration, and recurring customer value [6][24] - Capital allocation priorities include investing in organic growth, pursuing accretive bolt-on M&A, returning capital through share repurchases, and maintaining a modest growing dividend [10][39] - The company is committed to maximizing medium to long-term shareholder returns and has demonstrated this through significant share repurchases [5][18] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the company's growth trajectory, emphasizing the importance of customer-centric operations and the simplification of the organizational model [22][23] - The company expects overall core growth to moderate in Q4, with AHS core growth broadly in line with Q3 levels and very modest core growth at iOS [19][95] - Management remains confident in the healthcare market's resilience, citing aging demographics and increasing healthcare needs as long-term growth drivers [97] Other Important Information - The company successfully completed the spin-off of its Precision Technologies segment, now operating independently as Rallian, on June 28, 2025 [2] - Free cash flow for Q3 was $266 million, with trailing twelve-month free cash flow growing to $922 million [13][18] Q&A Session Summary Question: Margin performance and Q4 guidance - Management noted that Q3 margin performance was driven by revenue performance and cost discipline, with expectations to maintain cost discipline while reinvesting some resources in Q4 [31][32] Question: Impact of government shutdown on performance - The company indicated that its exposure to federal government funding is minimal, and the shutdown has not significantly impacted performance [34] Question: Capital allocation and buyback strategy - Management explained that the $1 billion share repurchase was based on strong free cash flow and attractive valuations, with a focus on smaller bolt-on acquisitions for growth [38][39] Question: Demand trends in AHS segment - Management reported sequential improvement in demand for healthcare capital equipment and consumables, driven by more certainty in legislative conditions [52] Question: Tax rate outlook - The CFO indicated that a mid-teens tax rate is a good framework for modeling through 2026, with potential risks from new proposals [53] Question: Demand by region - North America continues to perform strongly, while Western Europe remains soft, with mixed results in other regions [69]

Financial Performance - Fortive's Q3 2025 revenue reached $1027 million, with a reported growth of +23% and core growth of +19%[14] - Adjusted Gross Profit was $651 million, with an Adjusted Gross Margin of 633%[14] - Adjusted EBITDA grew +104% year-over-year to $309 million, resulting in an Adjusted EBITDA Margin of 301%[14] - Adjusted EPS increased by +153% year-over-year to $068[14] - Free Cash Flow was $266 million, with a Trailing Twelve Month (TTM) Free Cash Flow of $922 million and TTM FCF Conversion on Adj Net Income of 103%[14] Segment Performance - Intelligent Operating Solutions (IOS) revenue was $699 million, with core growth of +22% and an Adjusted EBITDA Margin of 346%[17] - Advanced Healthcare Solutions (AHS) revenue was $328 million, with core growth of +11% and an Adjusted EBITDA Margin of 281%[20] Capital Allocation - The company executed $1 billion of share repurchases in Q3, retiring approximately 21 million shares at an average price of ~$48 per share[9, 13, 25] - Cash and equivalents stand at $04 billion, with gross debt at $33 billion and net debt at $29 billion[23] Guidance - The company raised its FY 2025 adjusted EPS guidance to a range of $263 to $267[9, 26] Strategic Initiatives - The company is diligently executing the Fortive Accelerated strategy, focusing on faster, profitable organic growth powered by FBS Amplified[9, 11]

Core Viewpoint - Fortive raised its annual profit forecast after exceeding third-quarter sales and profit estimates, driven by strong demand for its industrial automation software technology, resulting in a 10% increase in its shares [1] Group 1 - Fortive's third-quarter performance surpassed sales and profit expectations [1] - The company experienced robust demand for its industrial automation software technology [1] - Following the positive earnings report, Fortive's shares rose approximately 10% [1]

Financial Performance - Fortive reported Q3 2025 revenue of $1.03 billion, a 2.3% increase year-over-year, with core revenue growth of 1.9%[7] - Adjusted diluted net EPS for Q3 2025 was $0.68, reflecting a 15.3% increase compared to Q3 2024[6] - The company raised its full year 2025 guidance for adjusted diluted net EPS to a range of $2.63 to $2.67, up from the previous range of $2.50 to $2.60[5] - GAAP net income for Q3 2025 was $117 million, with a margin of 11.4%, up 4.9% year-over-year[7] - Adjusted EBITDA for the quarter was $309 million, a 10.4% increase year-over-year, with an adjusted EBITDA margin of 30.1%[7] - Fortive's total sales for the three months ended September 26, 2025, reached $1,027.1 million, a 2.7% increase from $1,003.7 million in the same period last year[22] - Operating profit for the total company was $159.6 million, down from $172.0 million year-over-year, resulting in an overall operating margin of 15.5% compared to 17.1%[22] - Net earnings for the three months ended September 26, 2025, were $117.0 million, with a net earnings margin of 11.4%[49] - Adjusted net earnings (Non-GAAP) for the three months ended September 26, 2025, were $228.3 million, translating to an adjusted diluted net earnings per share of $0.68[51] Segment Performance - The Intelligent Operating Solutions segment generated revenue of $699 million, a 2.6% increase year-over-year[9] - Advanced Healthcare Solutions segment revenue was $328 million, reflecting a 1.9% increase year-over-year[9] - Intelligent Operating Solutions segment reported sales of $698.8 million, up from $681.3 million, while Advanced Healthcare Solutions segment sales increased to $328.3 million from $322.4 million[22] - Core revenue growth (Non-GAAP) for Intelligent Operating Solutions was 2.2%, and for Advanced Healthcare Solutions was 1.1% for the three months ended September 26, 2025[48] - Adjusted operating profit for Intelligent Operating Solutions was $229.2 million, with an adjusted operating profit margin of 32.8% for the three months ended September 26, 2025[50] Cash Flow and Capital Expenditures - GAAP operating cash flow for Q3 2025 was $295 million, with trailing twelve months (TTM) GAAP operating cash flow of $1,019 million[7] - Free cash flow for Q3 2025 was $266 million, with TTM free cash flow of $922 million, representing a 5.5% increase year-over-year[7] - The company reported a net cash provided by operating activities of $717.3 million, down from $1,024.6 million in the previous year[28] - Free cash flow is defined as net cash provided by operating activities less capital expenditures, indicating the company's ability to generate cash without external financing[46][47] - Operating Cash Flows (GAAP) for the trailing twelve months totaled $1,019.2 million, with a quarterly high of $327.7 million in the most recent quarter[52] - Free Cash Flow (Non-GAAP) for the trailing twelve months reached $921.9 million, with the latest quarter showing $266.1 million[52] - Capital expenditures (GAAP) for the trailing twelve months amounted to $97.3 million, with the most recent quarter at $28.6 million[52] - The latest quarterly Free Cash Flow (Non-GAAP) of $266.1 million represents a 47.8% increase compared to the same quarter last year[52] - The company continues to invest in property, plant, and equipment, with total capital expenditures for the trailing twelve months at $97.3 million[52] Share Repurchase and Guidance - Fortive executed $1 billion in share repurchases during the quarter, representing approximately 6% of diluted shares outstanding[6] - Fortive repurchased common shares worth $1,345.1 million during the nine months ended September 26, 2025[28] Balance Sheet and Assets - Cash and equivalents decreased to $430.8 million from $813.3 million as of December 31, 2024[26] - Total assets decreased to $11,886.7 million from $17,016.1 million as of December 31, 2024[26] - Current liabilities increased to $2,469.5 million from $2,238.4 million, primarily due to an increase in the current portion of long-term debt[26] - Fortive's goodwill increased to $7,276.2 million from $7,216.0 million as of December 31, 2024[26] Restructuring and Other Initiatives - The company initiated a discrete restructuring plan in Q4 2024 related to a significant separation, expected to be completed by the second half of 2026[39] - The company recorded a gain from an immaterial divestiture in May 2025, which is excluded from adjusted performance metrics to provide clearer operational insights[43] Foreign Currency Impact - The impact of foreign currency translation on revenue was a decrease of 0.7% for the total Fortive segment in the three months ended September 26, 2025[48]